Automated targeted PCR
Manual targeted PCR
T cell detection
Additional COVID-19 resources
Research solution for COVID-19Learn how QIAGEN can support research to better understand the SARS-CoV-2 virus.
Latest COVID-19 updates from QIAGENStay up-to-date with our latest news and product developments here.
Battling tuberculosis in the time of COVID-19Dr. Story brings tuberculosis testing and treatment to susceptible homeless communities during COVID-19.
Tailored oligonucleotides for SARS-CoV-2 detectionOEM by QIAGEN provides customized primers and probes. We have ramped up and prioritized production that specifically supports SARS-CoV-2 detection.
The next generation of syndromic insights
Harness the full potential of multiplex syndromic testing and confidently provide clinical insights to patients with the highest level of versatility.
QIAGEN Digital Insights
Bioinformatics analysis of SARS-CoV-2 with QIAGEN Digital Insights
To support the efforts of labs sequencing the SARS-CoV-2 virus on the front lines of the COVID-19 pandemic, QIAGEN is offering free temporary licenses to researchers worldwide involved with COVID-19 research and response.
Redefining automated sample processing
Fully automate QIAGEN gold-standard spin-column purification procedures with the new QIAcube Connect instrument.
EZ1 DSP Virus Kit
Contains all required reagents for automated purification
The EZ1 DSP Virus Kit is ideal for automated, simultaneous purification of viral nucleic acids and bacterial DNA from 1–6 or 1–14 human biological specimens.
QIAamp Viral RNA Mini Kit
For isolation of viral RNA from cell-free body fluids
By binding viral RNA to the QIAamp silica membrane, the QIAamp Viral RNA Mini Kit simplifies purification of viral RNA from cell-free body fluids with fast spin-column or vacuum procedures. The procedure can be fully automated.
EZ1 Advanced XL
For automated nucleic acid purification
With EZ1 Advanced XL you can fully automate your nucleic acid purification from a wide range of sample types relevant for molecular diagnostics.